What CPAP Alternatives Actually Work
An honest look at oral appliances, positional therapy, and the new generation of implantable nerve stimulators — and which patients each one is actually right for.
CPAP therapy is the gold standard treatment for obstructive sleep apnea, backed by decades of evidence for reducing apnea severity, improving oxygen saturation, lowering cardiovascular risk, and reducing daytime sleepiness. It is also, for a substantial portion of the people who try it, genuinely difficult to tolerate. Estimates of long-term CPAP adherence vary widely, but most studies suggest that 30 to 50 percent of people prescribed CPAP fail to use it at clinically recommended levels — four or more hours per night on at least 70 percent of nights. This creates a real clinical problem: the evidence-based treatment exists, but many patients cannot or will not use it consistently.
For people who cannot tolerate CPAP, have tried it without success, or are seeking alternatives for specific reasons, the question of what actually works is legitimate and important. The honest answer is nuanced: several alternatives have meaningful evidence for specific patient populations, but none match the efficacy of well-tolerated CPAP for moderate-to-severe OSA.
Why CPAP Non-Adherence Happens
Understanding why CPAP fails for some patients helps clarify what alternatives might address those specific barriers. Common reasons for non-adherence include: mask discomfort or leakage from poor fit; claustrophobia or anxiety about wearing the mask; difficulty tolerating continuous positive airway pressure (particularly on exhalation); aerophagia (swallowing air); nasal congestion that makes nasal masks uncomfortable; and the general inconvenience of a device that requires nightly setup and regular cleaning.
Many cases of CPAP failure that appear to be permanent are actually addressable with proper troubleshooting. Before concluding that CPAP is not an option, most sleep medicine physicians recommend at minimum: a mask fitting appointment with a respiratory therapist to optimize mask selection and sizing, adjustment of pressure settings (the initial pressure prescribed is frequently not optimal), a trial of auto-titrating CPAP (APAP) which automatically adjusts pressure breath-by-breath, and desensitization strategies for claustrophobia. The rate of successful CPAP use is substantially higher with adequate support than with device delivery and minimal follow-up.
Mandibular Advancement Devices
Mandibular advancement devices (MADs) — also called oral appliances or mandibular repositioning devices — are custom-fabricated dental devices that hold the lower jaw slightly forward, preventing the retroposition of the tongue and soft palate that causes airway collapse in obstructive sleep apnea. They are fitted by dentists or oral medicine specialists with training in sleep-disordered breathing.
MADs are the most extensively studied CPAP alternative and have the strongest evidence base among alternatives for OSA. A systematic review in Sleep Medicine Reviews found that MADs produced clinically significant reductions in AHI in patients with mild-to-moderate OSA, with many patients achieving normal AHI values (below 5). For severe OSA, MADs reduce AHI substantially but typically leave residual disease more often than CPAP, making them a second-line option for severe presentations unless CPAP failure is documented.
The American Academy of Sleep Medicine and the American Academy of Dental Sleep Medicine recommend oral appliances as an acceptable alternative to CPAP for adults with mild-to-moderate OSA who prefer them, or for patients who fail CPAP. Efficacy is verified through follow-up sleep testing after device titration, since the appropriate amount of jaw advancement varies between individuals and requires adjustment.
Side effects include jaw soreness, tooth discomfort, and temporary changes in bite, which are common in the early weeks of use and generally resolve with adjustment. More persistent dental side effects (including modest changes in tooth position and occlusion) are possible with long-term use and should be monitored by the prescribing dentist. Patients with significant temporomandibular joint disease are generally not candidates for MADs.
Positional Therapy
Obstructive sleep apnea is significantly worse in the supine (back-lying) position for many patients. The tongue and soft palate fall backward under gravity when lying on the back, reducing the upper airway caliber and increasing the likelihood of collapse. For patients who have significantly fewer apnea events in lateral (side) sleeping positions, positional therapy — strategies to maintain lateral sleep position throughout the night — can meaningfully reduce OSA severity.
Classic positional therapy involved wearing a tennis ball in a pocket sewn to the back of a sleep shirt, producing discomfort when the sleeper rolled onto their back. This approach, while effective, has poor long-term adherence. Newer positional devices — vibrating position sensors worn on the chest or upper back that gently alert the sleeper when they roll supine — have better adherence data and produce comparable position shifts to the tennis ball method without the discomfort.
Positional therapy is appropriate only for patients with documented positional OSA — defined as an AHI that is at least twice as high in the supine position as in the lateral position. This criterion is met in roughly 50 to 70 percent of OSA patients, making positional therapy a viable option for many but not all. For patients with non-positional OSA, positional therapy produces minimal benefit. A follow-up sleep study to confirm AHI normalization with positional therapy is recommended before abandoning other treatments.
Upper Airway Stimulation (Inspire Therapy)
Hypoglossal nerve stimulation — commercially available as the Inspire device — is a surgically implanted system that delivers mild electrical stimulation to the hypoglossal nerve (which controls tongue movement) during each breath, preventing the tongue from falling backward and obstructing the airway. The device is activated with a small handheld remote before sleep and delivers automatically timed stimulation throughout the night.
Inspire represents the most significant advance in OSA treatment since CPAP and is the treatment option with the strongest evidence for moderate-to-severe OSA in CPAP-intolerant patients. The STAR trial — a multicenter pivotal study published in the New England Journal of Medicine in 2014 — found that upper airway stimulation reduced the median AHI from 29.3 events per hour at baseline to 9.0 events per hour after twelve months, a 68 percent reduction, with 66 percent of patients achieving a response (AHI reduction of at least 50 percent and residual AHI below 20). Quality of life, daytime sleepiness, and functional outcomes also improved significantly.
The procedure requires surgery under general anesthesia and is not appropriate for all patients. FDA approval specifies eligibility criteria including moderate-to-severe OSA (AHI 15–65), CPAP intolerance, absence of complete concentric collapse at the palate level on drug-induced sleep endoscopy, and absence of severe obesity (BMI < 32). For patients who meet criteria, Inspire therapy offers a highly effective alternative to CPAP without nightly device wear.
Weight Loss and Bariatric Surgery
Obesity is the strongest modifiable risk factor for obstructive sleep apnea. Fat deposition in the parapharyngeal spaces reduces upper airway caliber, and increased abdominal girth reduces functional residual capacity in the lungs, both of which worsen airway collapsibility during sleep. For obese patients with OSA, weight loss produces proportionally large reductions in OSA severity.
A 10 percent reduction in body weight produces approximately a 26 percent reduction in AHI, according to findings from the Sleep Heart Health Study. Bariatric surgery, which produces larger and more durable weight loss than lifestyle intervention alone, has been shown to resolve or markedly improve OSA in 80 percent or more of patients who achieve significant weight loss. However, OSA does not necessarily resolve completely with weight loss, residual disease requires documentation, and CPAP may still be needed after weight reduction — particularly during the weight loss period itself.
Surgical Options for the Upper Airway
Several upper airway surgical procedures exist for OSA, targeting structural abnormalities that predispose to airway collapse. Uvulopalatopharyngoplasty (UPPP) — resection of the uvula, part of the soft palate, and redundant oropharyngeal tissue — was historically the most common surgical approach. However, long-term outcome data shows high rates of relapse and inconsistent efficacy, and UPPP has largely been supplanted by more targeted procedures and upper airway stimulation for most presentations.
Maxillomandibular advancement (MMA) — surgical advancement of both the upper and lower jaw to permanently expand the oropharyngeal airway — has the strongest evidence of any upper airway surgical procedure, with success rates of 85 to 95 percent in selected patients. It is a major jaw surgery requiring extensive recovery and is appropriate primarily for patients with significant retroglossal obstruction who are not candidates for oral appliances or upper airway stimulation.
For patients with anatomically specific contributions to OSA — enlarged tonsils or adenoids (particularly in children and young adults), nasal obstruction, turbinate hypertrophy, or severe retrognathia — targeted surgical correction of these anatomical factors can meaningfully reduce OSA severity, though rarely eliminating it completely without additional treatment.
Choosing the Right Alternative
The appropriate CPAP alternative depends on OSA severity, patient anatomy, weight, lifestyle, the reason for CPAP intolerance, and patient preference. For mild-to-moderate OSA in a patient who has tried and failed CPAP, a custom oral appliance is typically the first alternative — it is non-invasive, reversible, well-tolerated, and has the strongest evidence base among non-surgical alternatives. For severe OSA with documented CPAP intolerance in an appropriate candidate, upper airway stimulation (Inspire) is now the standard-of-care alternative. For positional OSA, positional therapy is a reasonable low-cost option.
All alternative treatments require follow-up sleep testing to confirm adequate OSA control — efficacy cannot be assumed from symptom improvement alone. Untreated or inadequately treated moderate-to-severe OSA carries meaningful cardiovascular risk, and treatment adequacy should be objectively verified.
Frequently Asked Questions
Which CPAP alternative is most effective?
Efficacy depends on OSA severity and individual factors. For mild-to-moderate OSA, custom oral appliances achieve OSA control in a substantial proportion of patients. For moderate-to-severe OSA with CPAP intolerance, upper airway stimulation (Inspire) is currently the most effective alternative, with response rates of 66 percent or more in eligible patients. All alternatives should be followed by sleep testing to confirm adequate control.
Can I treat sleep apnea without a machine?
Yes, for some patients. Oral appliances, positional therapy, upper airway stimulation, and weight loss are all non-CPAP options with varying levels of evidence. Which is appropriate depends on your specific anatomy, OSA severity, and history with CPAP. A sleep medicine specialist can help determine which approach is most suitable for your individual presentation.
Is Inspire therapy covered by insurance?
Most major insurance carriers, including Medicare, cover Inspire therapy for patients who meet eligibility criteria: documented moderate-to-severe OSA, failure of CPAP, appropriate anatomy (verified with drug-induced sleep endoscopy), and specific AHI and BMI thresholds. Coverage decisions require prior authorization. Consult with a sleep medicine physician who offers Inspire therapy to understand the coverage process for your plan.
Can weight loss alone cure sleep apnea?
For some patients with obesity-related OSA and significant weight loss, sleep apnea may resolve completely. More commonly, weight loss reduces OSA severity substantially without eliminating it entirely. Even if OSA resolves with weight loss, a follow-up sleep study is needed to confirm this — residual disease requiring treatment is common and cannot be assumed absent based on symptom improvement alone.
Moving Forward
The research landscape on this topic has matured to the point where clear, evidence-based recommendations are available — and where the gap between what the evidence shows and what most people actually receive as treatment remains an important public health problem. Understanding the research, seeking the appropriate treatment for your specific situation, and following through with the behavioral work that evidence-based protocols require are the three steps most likely to produce lasting improvement. The evidence is clear; the access is increasingly available; the work, for those who commit to it, produces results that medication alone cannot match over time.
For anyone still in the early stages of understanding their sleep problem — not yet sure whether what they have is clinical insomnia, a physiological disorder, a circadian issue, or simply inadequate sleep opportunity — the most productive next step is a two-week sleep diary and a conversation with a physician who can review it in clinical context. From that foundation, the appropriate next intervention becomes considerably clearer.
Treating the Behavioral Sleep Component
Whether you use CPAP, an oral appliance, or another OSA intervention, none of these devices address the conditioned arousal and cognitive hyperarousal that many apnea patients develop over years of fragmented sleep. A structured CBT-I program runs in parallel to whatever physical treatment you are using. Sleep Reset delivers the complete CBT-I protocol — sleep restriction, stimulus control, cognitive restructuring — with a personal sleep coach, making it a practical complement to any airway treatment for patients dealing with persistent insomnia alongside their diagnosed sleep disorder.
Disclosure
Sleep Editorial is an independent publication. This article was reported and written without compensation from any product or service mentioned. Sleep Editorial does not provide medical advice; consult a qualified clinician for diagnosis and treatment.
More from Sleep Apnea